Market Overview

Benzinga's Top Pre-Market Losers

Related HMPR
Hampton Roads Bankshares Promotes Denise Hinkle to Chief Human Resources Officer
Thomas Dix Appointed CFO of Hampton Roads Bankshares
Related VRTX
JPMorgan, Canaccord Confident That Vertex's CF Drug Will Get FDA Approval
Vertex Shares Rally As FDA Panel Backs Orkambi; HC Wainwright Analyst Offers Thoughts

Hampton Roads Bankshares Inc (NASDAQ: HMPR) dipped 31.34% to $2.41 in the pre-market session. HMPR's trailing-twelve-month ROE is -55.63%

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) moved down 18.27% to $53 in the pre-market session. Vertex corrected and provided additional data from the recent interim analysis of an ongoing Phase 2 study of VX-809 and KALYDECO™ among adults with cystic fibrosis (CF) who have two copies (homozygous) of the F508del mutation.

Facebook Inc (NASDAQ: FB) shares fell 1.91% to $31.30 in the pre-market trading. FB's PEG ratio is 1.67.

Zynga Inc (NASDAQ: ZNGA) dipped 1.36% to $6.52 in the pre-market session. AMD's trailing-twelve-month operating margin is -43.47%.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (HMPR + FB)

Around the Web, We're Loving...

Get Benzinga's Newsletters